Brief: Inozyme Pharma Reports Full Year 2021 Financial Results
15/03/2022 21:28
March 15 (Reuters) - Inozyme Pharma Inc INZY.O :
* INOZYME PHARMA REPORTS FULL YEAR 2021 FINANCIAL RESULTS
AND
PROVIDES BUSINESS HIGHLIGHTS
* INOZYME PHARMA - EXPECTS EXISTING CASH, CASH EQUIVALENTS,
INVESTMENT WILL BE SUFFICIENT TO FUND OPERATING EXPENSES,
CAPITAL EXPENDITURES INTO Q1 2023
Source text for Eikon: ID:nGNX1Jx1dW
Further company coverage: INZY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inozyme Pharma
See all newsBrief: Inozyme Pharma postpones 2025 annual meeting of stockholders
U.S. RESEARCH ROUNDUP-Advansix, Cognizant, Inozyme Pharma
U.S. STOCKS ON THE MOVE-Netflix, Acadia Pharma, CoreWeave
U.S. STOCKS ON THE MOVE-Inozyme Pharma, Emerson Electric, Stanley Black & Decker
Inozyme Pharma rises over 175% on $270 million buyout deal with BioMarin